Bernhard Huitfeldt

3.2k total citations · 1 hit paper
11 papers, 2.4k citations indexed

About

Bernhard Huitfeldt is a scholar working on Economics and Econometrics, Statistics and Probability and Immunology. According to data from OpenAlex, Bernhard Huitfeldt has authored 11 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Economics and Econometrics, 4 papers in Statistics and Probability and 3 papers in Immunology. Recurrent topics in Bernhard Huitfeldt's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Statistical Methods in Clinical Trials (4 papers) and Meta-analysis and systematic reviews (3 papers). Bernhard Huitfeldt is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Statistical Methods in Clinical Trials (4 papers) and Meta-analysis and systematic reviews (3 papers). Bernhard Huitfeldt collaborates with scholars based in United Kingdom, Sweden and Belgium. Bernhard Huitfeldt's co-authors include H. Zeidler, Eric Veys, Ben A. C. Dijkmans, Sjef van der Linden, B Amor, Ignazio Olivieri, Maxime Dougados, A. Cats, Andrei Călin and G Pasero and has published in prestigious journals such as Gastroenterology, Clinical Infectious Diseases and Journal of Pharmaceutical Sciences.

In The Last Decade

Bernhard Huitfeldt

11 papers receiving 2.3k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of Spondylarthropathy

1991 1.7k citations Maxime Dougados, Sjef van der Linden et al. Arthritis & Rheumatism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernhard Huitfeldt United Kingdom	8	1.8k	846	681	412	329	11	2.4k
H. Sörensen Germany	17	2.4k 1.3×	1.1k 1.2×	948 1.4×	206 0.5×	191 0.6×	25	2.9k
Elisabeth Märker‐Hermann Germany	25	2.0k 1.1×	1.6k 1.9×	661 1.0×	176 0.4×	236 0.7×	95	2.9k
Anne Nicholls United Kingdom	10	1.7k 0.9×	1.2k 1.4×	544 0.8×	224 0.5×	215 0.7×	15	2.9k
J. Sieper Germany	18	1.7k 0.9×	897 1.1×	611 0.9×	128 0.3×	123 0.4×	84	2.3k
Nigil Haroon Canada	28	2.4k 1.3×	1.4k 1.6×	890 1.3×	165 0.4×	172 0.5×	123	2.9k
Rafael Valle‐Oñate Colombia	18	1.6k 0.9×	799 0.9×	592 0.9×	120 0.3×	127 0.4×	59	1.9k
Millicent Stone Canada	25	1.7k 0.9×	823 1.0×	567 0.8×	117 0.3×	78 0.2×	43	2.1k
Elizabeth C. Hsia United States	34	3.1k 1.7×	1.7k 2.0×	1.6k 2.4×	243 0.6×	231 0.7×	109	3.9k
Masanori Kawashima Japan	19	722 0.4×	926 1.1×	438 0.6×	94 0.2×	141 0.4×	38	2.0k
Santiago Muñoz‐Fernández Spain	27	1.2k 0.6×	463 0.5×	474 0.7×	59 0.1×	154 0.5×	75	1.8k

Countries citing papers authored by Bernhard Huitfeldt

Since Specialization

Citations

This map shows the geographic impact of Bernhard Huitfeldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Huitfeldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Huitfeldt more than expected).

Fields of papers citing papers by Bernhard Huitfeldt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Huitfeldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Huitfeldt. The network helps show where Bernhard Huitfeldt may publish in the future.

Co-authorship network of co-authors of Bernhard Huitfeldt

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Huitfeldt. A scholar is included among the top collaborators of Bernhard Huitfeldt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Huitfeldt. Bernhard Huitfeldt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Huitfeldt, Bernhard, et al.. (2011). The draft FDA guideline on non‐inferiority clinical trials: a critical review from European pharmaceutical industry statisticians. Pharmaceutical Statistics. 10(5). 414–419. 24 indexed citations

2.

Huitfeldt, Bernhard, et al.. (2001). Choice of Control in Clinical Trials—Issues and Implications of ICH-E10. Drug Information Journal. 35(4). 1147–1156. 10 indexed citations

3.

Köpcke, Wolfgang, David R. Jones, Bernhard Huitfeldt, & Karsten Schmidt. (1998). Statistics and Statisticians in European Drug Regulatory Agencies. Drug Information Journal. 32(1). 243–251. 4 indexed citations

4.

Dougados, Maxime, Sjef van der Linden, Marjatta Leirisalo‐Repo, et al.. (1995). Sulfasalazine in the treatment of spondylarthropathy. Arthritis & Rheumatism. 38(5). 618–627. 275 indexed citations

5.

Dougados, Maxime, Sjef van der Linden, Bernhard Huitfeldt, et al.. (1991). The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of Spondylarthropathy. Arthritis & Rheumatism. 34(10). 1218–1227. 1687 indexed citations breakdown →

6.

Huitfeldt, Bernhard. (1986). Statistical Aspects of Clinical Trials of Antibiotics in Acute Infections. Clinical Infectious Diseases. 8(Supplement_3). S350–S357. 16 indexed citations

7.

Sjövall, Jan, et al.. (1984). Correlation Between the Bioavailability of Microencapsulated Bacampicillin Hydrochloride in Suspension and In Vitro Microcapsule Dissolution. Journal of Pharmaceutical Sciences. 73(2). 141–145. 6 indexed citations

8.

Claghorn, James L., et al.. (1983). A double-blind evaluation of zimelidine in comparison to placebo and amitmptyline in patients with major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 7(2-3). 367–382. 30 indexed citations

9.

Rosén, Anders, Bo Ursing, Thor Alm, et al.. (1982). A Comparative Study of Metronidazole and Sulfasalazine for Active Crohn's Disease: The Cooperative Crohn's Disease Study in Sweden. Gastroenterology. 83(3). 541–549. 48 indexed citations

10.

Ursing, Bo, Thor Alm, F Bárány, et al.. (1982). A Comparative Study of Metronidazole and Sulfasalazine for Active Crohn's Disease: The Cooperative Crohn's Disease Study in Sweden. Gastroenterology. 83(3). 550–562. 256 indexed citations

11.

Bäcklund, Lars, et al.. (1974). Choice of Variables for Predicting the Heart Volume. Upsala Journal of Medical Sciences. 79(2). 97–102. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact